BioCentury | Feb 1, 2019
Company News
Bridge Biotherapeutics gets rights to kinase inhibitor from Korea Research Institute
...Safety. Korea Research Institute of Chemical Technology, Daejeon, South Korea Bridge Biotherapeutics Inc., Seongnam, South Korea Business: Cancer
Chris Lieu
Bridge Biotherapeutics Inc.
Korea Research Insitute of Chemical Technology...